Inhibiting the binding of apoB-containing lipoproteins to SMC-generated proteoglycans, for example by administering a vaccine to generate antibodies that block this interaction, represents the exciting possibility of using immunization to block lipoprotein retention in the artery wall lifelong for atherosclerosis prevention [62, 63]. The gene discussed is APOB; the disease is atherosclerosis.